Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Oncology, Rare Disease Drugs Dominate New China Approvals
Mix Of Nods For Foreign, Local Firms
Dec 09 2020
•
By
Brian Yang
RARE DISEASE, CANCER DRUGS TOP CHINA NEW DRUG APPROVAL LIST • Source: Shutterstock
More from China
More from Asia